Procter & Gamble Health schedules analyst meet on June 18

Procter & Gamble Health Limited will host a virtual connect meeting with analysts and institutional investors on June 18, 2026, to engage with the investment community. The session is scheduled to begin at 2:30 p.m. IST and will be conducted via virtual mode. The company confirmed that no unpublished price sensitive information will be disclosed during this interaction.

Institutional investors and analysts interested in participating are required to complete their registration by June 8, 2026. The meeting link and specific access details will be shared separately only with those who have successfully registered. This procedural step ensures that only verified participants can join the discussion.

The meeting serves as a platform for the company to interact with stakeholders without sharing material non-public information. Participants can direct any queries regarding the registration process or the event to the designated company official via email.

Meeting Details

Day and Date	Time	Mode of Meeting	Type of Meeting
Thursday, June 18, 2026	2:30 p.m. (IST)	Virtual mode	Group meeting

The registration deadline is strictly set for June 8, 2026. Procter & Gamble Health has emphasized that the session is purely for informational purposes and will not involve the disclosure of any unpublished price sensitive data.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.72%	+0.35%	+12.52%	+10.19%	+5.51%	+7.83%

Procter & Gamble Health Limited's Board has approved the re-appointment of Mr. S. Madhavan as Independent Director for a term of five years effective November 15, 2026. The decision, taken at a Board meeting held on May 26, 2026, follows the recommendation of the company's Nomination & Remuneration Committee. The re-appointment is subject to the approval of the shareholders.

The company confirmed that Mr. Madhavan meets the criteria of independence laid down in Section 149 of the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It was further affirmed that he is not debarred or disqualified from holding the office of a Director by any order from SEBI, the Ministry of Corporate Affairs, or any other statutory authority. Additionally, Mr. Madhavan does not hold any shares in the company.

The re-appointment is pursuant to the completion of Mr. Madhavan's first tenure. The company provided the requisite details in compliance with SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.

Re-appointment Details

Detail	Information
Reason of Change	Re-appointment of Mr. S. Madhavan as Independent Director for a period of five years pursuant to completion of first tenure.
Date of Re-appointment	November 15, 2026
Term of Re-appointment	Five (5) years, i.e., from November 15, 2026 to November 14, 2031. Subject to approval of shareholders.
Relationship with Directors	None of the Directors of the Company are related to Mr. S. Madhavan.